Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ihub is changin the entire site right now
thank you for that
a lot of new names this week! welcome and do your OWN DD, a lot of people seem to invest off what they read, not research GLTA
GO ENTI!
little bit of news this morning, anyone know how premarket trades go thru in a penny stock?
very true, just so much potential here
WhisperfromWallStreet VRAL Alert
Posted on 18 July 2010 by admin
Hello All, I hope everyone enjoyed there weekend and is ready for a big week of trading. Today's alert is a bio-tech company and we all know how explosive they can be. Remember last year when VERMILLION INC which traded on the pink sheets went from .05 to $28.45?? That was a 56,800% price gain!! Now Im not saying that is going to happen here but it does show you that when these little medical companies come out with good news the market can go crazy. Let's get to the alert. My new alert is Viral Genetics Inc., VRAL, and the stock closed Friday at 4.9 cents. Please begin your research here www.gold-american.com and here http://clicks.aweber.com/y/ct/?l=K15Ol&m=1dtogFKulu_ipC&b=fzcihwSH8729xeeup6Xq0w Here are a few facts to get you started. VRAL discovers and develops drug therapies. VRAL has been researching treatments and testing drug therapies for HIV/AIDS, Lyme Disease, Strep, Staph and drug resistant tumors. VRAL's lead scientist recently discovered a technology that may become new therapies and new vaccines for the deadly HIV virus. Recently, one of VRAL's lead scientists, Dr. M. Karen Newell, Ph.D., obtained nearly $1 million in new funding to support her promising research. The new grants have enabled VRAL, to accelerate the pace of its research, hire additional staff and move closer to its goal of bringing drug compounds to the marketplace. VRAL announced last month that it has granted a renowned London research team the right to investigate its HIV/AIDS drug compound. VRAL is moving in the right direction, and I look forward to seeing how this story develops. Biotech stocks have been particularly successful in the penny stock market, and whenever you can find one with a great story at a low price its worth a strong look. Here are some bio-tech stocks that exploded last year. VERMILLION INC went from 5 cents to $28! That's right, that's not a typo, 28 dollars, not 28 cents. 56,800% price gain!!! VKNG went from .003 to $1.00 in 3 weeks for a 33,233% price gain!! NEPH went from .10 to $2.63 for a 2530% price gain. As you can see there is potential for HUGE price gains for bio-tech stocks on the OTC market. VRAL has a strong story and with the right news it could be the next huge bio-tech winner. Get ready to book your profits with VRAL As always, do your own research, always use stop loss orders to protect yourself, and book your profits when in a position to do so. Good Investing, Mark If you do not trade with a broker that allows stops GET ONE. ChoiceTrades does allow stops and they only charge $5 commissions on OTC stocks. Open an account by following this link. http://clicks.aweber.com/y/ct/?l=K15Ol&m=1dtogFKulu_ipC&b=kE9ycHEiJvQEeC_HYqAVAQ We can now be found on Facebook at http://clicks.aweber.com/y/ct/?l=K15Ol&m=1dtogFKulu_ipC&b=9bRVuAnAJiBobExLUeIkWQ You can also follow us on Twitter at http://clicks.aweber.com/y/ct/?l=K15Ol&m=1dtogFKulu_ipC&b=UR9IN40UdrgpgXD7AIjdMg Important Disclaimer: WFWS Consulting Inc (who along with its affiliates, subsidiaries, officers, directors, representatives and agents is collectively referred to as "WFWS") maintains this website and newsletter as a service to its customers, who have paid for the publication of the information regarding their respective company or business. By using this website, you agree to the following terms of use, which WFWS may unilaterally change at any time. WFWS is not a Registered Investment Advisor or a Broker/Dealer. No Financial Advice or Recommendation Made by WFWS: THIS IS A PAID ADVERTISEMENT USED TO GENERATE EXPOSURE OF THE COMPANY OR COMPANIES MENTIONED IN THE NEWSLETTER. The advertisements and materials relating to WFWS's respective customers are not intended directly or indirectly provide advice as to the advisability of investing in, purchasing, holding or selling such securities. Instead WFWS's customers have prepared and paid for the advertising; and the publications are not endorsements, recommendations, analysis or advisors of any nature by WFWS. WFWS does not endorse any opinions or recommendations regarding the materials advertised, nor does it give tax or financial advice or advocate the purchase or sale of any security or investment. All information provided on the WFWS website pertaining to investing, stocks, securities must be understood as information provided and not financial advice. No Representation as to Content of Advertisement: In preparing this publication, WFWS has relied upon information supplied by its customers, which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, WFWS and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. WFWS is not responsible for any claims made by the companies advertised herein. BY ACCESSING THIS WEBSITE, YOU AGREE THAT THE INFORMATION PROVIDED IS "AS IS" AND WITHOUT WARRANTY, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION CURRENTNESS OR RELIABILITY OF THE CONTENT OF THE ADVERTISEMENTS MAINTAINED ON THIS WEBSITE; AND WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. WFWS shall not be liable for any damage or costs arising out of or in any way connected with your use of the materials or advertisements provided or accessed through this website. No Offer of Securities: None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead WFWS strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. WFWS does not offer such advice or analysis, and WFWS further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. Compensation: WFWS received a fee of twenty thousand dollars cash from a third party (Imperial Consulting Network, Inc.) for this VRAL advertisement. This compensation should be viewed as a potential conflict of interest. Buying and Selling of Shares: WFWS's affiliates, officers, directors and employees may have also bought or may buy the shares discussed in this report and may profit in the event those shares rise in value. WFWS intends to any sell shares in the event the shares rise in value. WFWS may sell its shares for less than target prices given in opinions. WFWS will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market. Public Filings: WFWS urges its readers who are considering an investment in a specific company to check the company's filings with the Securities and Exchange Commission ("SEC") on the SEC's Edgar Website located at http://clicks.aweber.com/y/ct/?l=K15Ol&m=1dtogFKulu_ipC&b=6ogwWbg2wSFyJp.GEdJ6LQ. No Liability Relating to External Links: This website contains links to other World Wide Web Internet sites, and WFWS is not responsible for the availability of these outside resources, or their contents. WFWS does not endorse, nor is it responsible for any of the contents, advertising products or other materials. Safe Harbor for Forward-Looking Statements: Information presented on the WFWS website contains "forward looking statements" within the meaning of Section 27A of the Securities Exchange Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. 1900 Empire Blvd. #212 Webster, New York 14580 To unsubscribe or change subscriber options visit
look what i found!!
ur talkin about maino i believe
"them" could be katy perry and snoop dogg, the other day someone posted those two doing a video shoot off of youtube forgot whoever that was sorry, but here is the link
awesome, thanks
anyone think that 1.75 million will show up when they turn in the financials?
Sorry thought i would post some actual recent information on the board. ENJOY and GO ASFX!!!!!
New Adult and Child 5-in-1 Non Contact Thermometer Increase in Production, Delivery and Distribution in Q3 2010
AMER SCIENTIFIC RES INC (OTC) (USOTC:ASFX)
Historical Stock Chart
3 Months : April 2010 to July 2010
Click Here for more AMER SCIENTIFIC RES INC (OTC) Charts.
American Scientific Resources, Inc. (the "Company" or "ASR") (Pink Sheets: ASFX) announced today that the Company has increased production of its new line of affordable, revolutionary 5-in-1 non contact thermometers to allow for various distribution channels to take full advantage of ASR's production capabilities.
(Photo: http://www.newscom.com/cgi-bin/prnh/20100507/NY01332)
Delivery to warehouse is expected in mid June. Final sub-component assembly and packaging will take place in the U.S. at ASR's Ohio facility, and ship to retailers around the world the first week in August. Full production capability of the consumer model exceeds 5000 units per day.
The new 5-in-1 non contact thermometer will provide the modern day consumer and healthcare workers around the globe with the ability to take a trauma-free, non invasive temperature, easily, quickly and safely with an innovative device which enables immediate care.
Jason M. Roth, Senior Vice President and Director of Business Development, stated, "In order to provide our current and new distributors with optimum service, we decided to increase production so that they can successfully and easily respond to the demand in the marketplace."
The Company has been marketing branded and private label options to various distributors, retailers and healthcare providers. The new 5-in-1 non contact consumer model has an MSRP of $49.95.
About American Scientific Resources, Inc.
American Scientific Resources, Inc. is both an operating company and the holding company for wholly owned subsidiary, Kidz-Med. The Company sources and designs innovative health and safety products, develops intellectual property and distributes through established relationships and channels both in-house and through its ever growing network of proven global healthcare distributors.
For more information, visit the corporate web site at www.americansci.com and the Company's subsidiary Kidz-Med at www.kidzmed.com.
Safe Harbor
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
Contact
American Scientific Resources Investor Relations
E-mail IR@americansci.com
Or call 561-948-4863
SOURCE American Scientific Resources, Inc.
American Scientific Resources, Inc. (the "Company" or "ASR") (Pink Sheets: ASFX) announces the following update in the affairs of the Company.
Introduction
This update is being provided by ASR to address the many inquiries received, and to also give some detail on the Company's development and growth. ASR also plans on updating the public continually with monthly updates.
ASR continues to implement its business plan
and improve on a number of initiatives and procedures including already announced projects, new initiatives and products and creating a better position with regard to financials, procedures, accounting and many other areas.
Numerous previously announced projects are progressing well.
Communication has improved with the Company's valued shareholders through improved Investor Relations and the soon to be released upgraded Investor Relations section of the corporate website. ASR has also taken steps to become even more transparent, specifically by making the recent Annual Report available on Pink Sheets. As always, the Company urges all shareholders to regularly visit the corporate website or view the filings on Pink Sheets.
Achievement highlights over the past year include:
* Financial improvement, and an increase in shareholder value
* The settlement or dismissal of legal actions
* The removal of the Caveat Emptor designation by Pink Sheets
* Fully current on all financial reporting
* All financial reporting and audits are up to date, and 2009 audits are complete
* New thermometer conception-to-production occurred within 6 months
* New Investor Relations firm
* New Board Members
* Operating under the ISO9001/13485 Directive of Quality Systems Manual and Good Manufacturing Practices to become fully approved FDA manufacturing facility
* New FDA approved products owned by the Company. Food and Drug Administration approval is being sought for new products.
* Significant private label thermometer and Disintegrator deals near completion
* New and exclusive distribution deals signed for other products
* Worldwide distribution agreements for multiple products executed
* Worldwide advances in legislation and awareness supporting the Needle Destruction Device (NDD)
* Significant media uptake on Company products
Both the new non-contact thermometer and Disintegrator production runs are on schedule for delivery to satisfy existing contracts with others in the pipeline.
2009 Results, Discussion and Comment
With the expansion of the management team and the implementation of the Company's restructuring and growth plan beginning in June 2009, substantial progress has been made; this work is reflected in the significant increase in traded market value of the Company's stock over the past 9 months.
* Assets are up due to the purchase of the Disintegrator patent
* Liabilities were $4,103,000 for the year ended December 31, 2008 and $3,500,000 for the year ended December 31, 2009, a reduction of $603,000. Current liabilities are down, including reductions of certain debt obligations.
* ASR is designated on Pink Sheets as having "current information". All of the audited financial statements are up to date and filed with the SEC along with other required disclosures.
American Scientific Resources, Inc.
Summary of Consolidated Financial Results
(US dollars in thousands except per share amounts)
2009
2008
Change
%
Selected Balance Sheet Data:
Total Assets
3,272
1,351
1,921
Up 142%
Current Liabilities
3,500
4,103
(603)
Down 15%
Shareholders' Deficit
(1,059)
(2,752)
1,693
Improved 62%
Selected Statement of Operations Data:
Product Sales
734
911
(176)
Off 19%
Operating, Sales & Admin. Expenses
(2,017)
(5,202)
3,185
Improved 61%
Interest Expense
(656)
(1,593)
936
Improved 59%
Net Loss to Common Shareholders
(3,347)
(6,407)
3,060
Improved 48%
Basic & Diluted Loss per Share
(0.0028)
(0.0437)
0.0409
Improved
Selected Key Ratios:
Gross Profit to Product Sales
42%
43%
-1%
Held steady
Total Liabilities to Total Assets
132%
304%
-171%
Improved 171%
Common Share Price Performance:
January 2,
December 31,
2009
2009
Closing Bid Price
0.0050
0.0139
0.0089
Up 178%
June 11,
April 14,
2009
2010
Closing Bid Price
0.0006
0.0144
0.0138
Up 2183%
Conception to Consumer
The process in taking a product conception to the retail shelves is quite an enormous undertaking. From design, to prototype, to tooling, to first articles to global distribution, ASR was able to complete this normally lengthy process for their new thermometer within the condensed time of 6 months in order to make it available for the 2010/2011 Cold/Flu season.
Since the Company decided to not just be a distributor, but also a manufacturer of medical devices, they have not only been operating under the ISO9001/13485 Directive of Quality Systems Manual and Good Manufacturing Practices, but ASR is preparing for an FDA audit as well as an ISO audit. Upon the successful completion of these audits, ASR would be a fully accredited manufacturer of medical devices.
Disintegrator Update
ASR is excited about satisfying the demand for the FDA approved Disintegrator and Disintegrator Plus. Ongoing sales are targeted both in the United States and overseas.
Manufacturing is well underway, and an announcement on developments and contracts will be out shortly.
During the first quarter of 2010, the Company received a follow on order from Bayer Sante. Additional orders are anticipated. Production of these customized units is well underway with delivery scheduled. Bayer Healthcare is one of the world's leading pharmaceutical companies, and utilizes the Disintegrator by providing it to patients who administer its Betaferon medication by injection. Disintegrator units are manufactured with Bayer Healthcare specific colors and logos, and are currently in daily use in France.
Jason Roth, ASR's Senior Vice President, commented, "Bayer Healthcare represents a world class partner for American Scientific. We are pleased to continue with the Bayer contract, and look forward to the additional stages of the contract as well as our continued relationship with them and with other customers and users worldwide."
In addition to the Bayer Healthcare Disintegrator and the Disintegrator Plus, the Company is developing a Non Government Organization (NGO) version, designed to be taken up globally by aid providers operating in areas where injections and immunizations are key in the fight against disease. The Disintegrator NGO provides foundations and aid organizations a cost effective way of destroying harmful needles at the point of use in developing countries worldwide. The Company is working on this project with its partners in manufacturing and front line aid providers.
According to the World Health Organization (WHO), it is estimated that globally 16 Billion injections are administered annually in developing and transitional countries alone. They also indicate that each year unsafe injections cause an estimated 1.3 million early deaths, a loss of 26 million years of life and an annual burden of $535 million USD in direct medical costs.
The Disintegrator is an exciting member of the product family at American Scientific, both with the home use Disintegrator Plus and the new NGO version. Both are designed to solve a global health issue that threatens the lives of millions of people - patients, healthcare professionals, aid workers as well as the general public - every year.
Disintegrator photo and more information can be found on www.disintegratorplus.com.
Thermometer Update
On May 10, 2010, ASR released an updated statement on how they increased production of its new line of affordable, revolutionary 5-in-1 non-contact thermometers to allow for various distribution channels to take full advantage of ASR's production capabilities.
The Company's new 5-in-1 non-contact thermometer provides a hygienic, trauma free and accurate temperature reading for the user and patient at a very competitive price. Through education and awareness, ASR aims to finally change the way the world takes a temperature.
Photo here: http://www.newscom.com/cgi-bin/pub/s?f=NCOM/prn&p1=20100507/NY01332&view=thumbnail_grid
Mebby Update
ASR placed an order with Medel Inc., (Mebby manufacturer), and is awaiting delivery of this first order. ASR is not currently selling these products, but expects to sell online in the coming months.
Mebby has an entire line of health and safety products designed to make child care much easier. For example, the breast-pump uses patented technology that provides a comfortable sucking-motion on a woman's breast, while at the same time reducing the fatigue of the mother. Also, for greater pump capacity, a duo-pump can pump both breasts at the same time in order to save time. Both pumps come with a convenient, stylish thermal bag with hot and cold packets. Additionally, the Mebby video baby monitor enables a parent to see a real-time image of their child day or night (with infrared technology).
To help with the sales and marketing of this new line of products, initial sales are being sought after in the southern California region, and ASR will be attending the ABC show in October 2010. Visit www.mebby.com to learn more about the line of products.
Corporate Website
ASR is working to improve the corporate website at the moment, and will have an updated Investor Relations section. The Company is also going to add sections, which will showcase product developments, new projects and news and events of interest worldwide relating to their products. For example, a "What's New" section will contain exciting insights into products coming to market.
The Company will announce shortly when it is completed, and all shareholders are encouraged to visit it regularly.
Upcoming PR
The Company was recently pleased to announce a substantial follow on Disintegrator order from Bayer Healthcare and, also anticipates further announcements shortly regarding additional Disintegrator orders and orders for the new thermometer.
Closing Comments
Dr. Christopher F. Tirotta, CEO/Chairman, stated, "We have had substantial challenges over the past years, but we look forward to improved results coming from the development and marketing of new products. Our restructuring and growth plan has yielded considerable positive developments over the past 9 months."
A lot of hard work lies ahead for ASR, yet the Company has taken many giant steps forward, and continues to move in a positive direction.
ASR urges shareholders who would like to be on the Company’s Investor E-mail List in order to receive all ASR updates to please e-mail IR@americansci.com.
About American Scientific Resources, Inc.
American Scientific Resources, Inc. is both an operating company and the holding company for wholly owned subsidiary, Kidz-Med. The Company sources and designs innovative health and safety products, develops intellectual property and distributes through established relationships and channels both in-house and through its ever growing network of proven global healthcare distributors. For more information, visit the corporate web site at www.americansci.com and the Company's subsidiary Kidz-Med at www.kidzmed.com.
Safe Harbor
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
Contact
American Scientific Resources Investor Relations
E-mail IR@americansci.com
Or call 561-948-4863
SOURCE American Scientific Resources, Inc.
American Scientific Resources, Inc. (the "Company" or "ASR") (Pink Sheets: ASFX) announces today that the Company is set to present retailers with its new Kidz-Med 5-in-1 Non-Contact Thermometer at NACDS Marketplace June 5-8, 2010 in San Diego, CA.
NACDS (National Association of Chain Drug Stores
) Marketplace is the premier annual retail event that retailers utilize to specifically meet with companies to find new and innovative products to bring to their stores in time for the 2010/2011 seasons.
Members of ASR's senior management team and advisors will be meeting with leading pharmacy chains and retailers.
While at NACDS, the company will be involved in high visibility programs including Meet the Market and Retailer Relay, with features in the Marketplace Product Showcase as well as advertisements in Drug Store News.
ASR will be at booth #1907 along with the Company's sales and marketing team, The Greenwood Group. The state of the art trade show booth provides ASR and its brands with high visibility on the highest traffic aisle at the show.
ASR's upcoming presence at NACDS follows the company's successful presentations at ECRM Cough Cold show held this past March in Dallas. This week, the Company is attending the ECRM Exports show in Miami, Florida.
The combined presence at NACDS, ECRM Cough Cold and ECRM Export now puts ASR and its brands in front of up to 100,000 points of distribution.
Dr. Christopher Tirotta, CEO of American Scientific, commented, "With a successful outcome from the ECRM event in March, we're excited to see the results of NACDS. We're confident that we have a very attractive advertising and marketing plan attached to our new thermometer that will entice retailers to select a product that not only fills demand in the marketplace but is affordable for today's consumer."
He continues, "As a company with the ability to bring innovative products to market, we look forward to building upon and formalizing concrete relationships at the show as well as meeting new partners for the future."
The Company urges shareholders who would like to be on ASR's Investor E-mail List in order to receive all ASR updates to please e-mail IR@americansci.com with the subject line "ADD TO E-MAIL LIST".
About American Scientific Resources, Inc.
American Scientific Resources, Inc. is both an operating company and the holding company for wholly owned subsidiary, Kidz-Med. The Company sources and designs innovative health and safety products, develops intellectual property and distributes through established relationships and channels both in-house and through its ever growing network of proven global healthcare distributors.
For more information, visit the corporate web site at www.americansci.com and the Company's subsidiary Kidz-Med at www.kidzmed.com.
Safe Harbor
This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approvals for anticipated actions.
Contact
American Scientific Resources Investor Relations
E-mail IR@americansci.com
Or call 561-948-4863
Media Contact – Erika McQuade
E-mail estanczak@americansci.com
Or call 847-386-1384 x. 201
SOURCE American Scientific Resources, Inc.
Just to point out the CC states to be a recap
Look forward to the company's Investor Re-cap call tomorrow! Call update will be available at 10:00am EDT on Friday, July 16th, 2010. The call can easily be accessed by dialing the toll-free number, 800-642-1687, in the US and Canada or 706-645-9291 for international calls. Simply dial in the new conference code, 78255016, when prompted.
someone forgot to read the email today!
all credit to kastlem of course
"We cannot and do not release any PR's that do not have any information that cannot be verified by the correct people."
"All information in our PR's is true and correct. "
that could be why when they said a month ago they were going to update there financials, in that email posted, they could still be workin on it cause of FINRA
HA, might wanna get that date checked
two mm left at 16 on the ask then two at 17, but there is a whole lot of 16s being bought
ha, i actually got some gear out this morning and forgot how dusty it is out there, best of wishes and a safe journey home once ENTI makes u a millionaire. GLTA!!!!
welcome back sir, r u back in states?
"We have some great ideas for the VSP technology that we'll be developing as we forge ahead with the booming MusicMatrix.com, announcing its celebrity spokesperson in the coming days, in line with our strategic DISH Network campaign and progressive internet hits."
things are about to get interesting
o yea IMO
EDIT: The CC tomorrow was called a "recap" so dont expect any fireworks there everyone
at least we can look forward to the conference call update with the info today??? always optimistic
outstanding!
think they just did one in feb, that should be out of the question for two years
man that ride was fun, we doubled from 4 cents to 8 cents in one day
just put in on my page, since everyone and there mom is visitin my page today because of im 1 year older i am confident we will see some good exposure
shared it on my facebook page
thahaha this is gonna be some really good tastin koolaid
that would be awesome, they love music and have done wonders for it
well said, and i agree, i just hope that they release the endorsement before further dilution occurs
indeed, our float is still extremely small compared to others, and imo once they sign someone people wont complain about how they diluted anymore, because we already know and have witnessed how easily this stock moves when its allowed. u can only tighten a spring for so long until its cant be tightened anymore, once u release whats holding it down........ use ur imagination
maybe not lil wayne cause i think he is still in jail, forgot about that part
at least LGTT doesnt have any dealings with korea yet, well at least i dont know about... lol
man these cheese and crackers i just ate went fantastic with all that wine i just read, but this is a stock board and i read it to get both side of the story and makes it interesting while we wait for celebrity endorsement, which leads me to my reasoning for posting, honestly after the past three artists they have announced, i believe they are staying within the hiphop rap area to sign a celebrity endorsement deal, especially after shareholders possibly could have ruined lady gaga for MM. take it how u want but if this celebrity has a "wow" factor as they state, and it is a *good* wow factor my pics are one of the following: Lil Wayne JayZ Drake Snoop Dog Will I Am and im even tossing in the possibility of Eminem. every single artist that i have just named is extremely extremely popular. and that is just my short list. i have a whole bunch more that i give the possibility to do wonders if they are signed. we already know that the right celebrity will do wonders for a stock, george foreman made meineke and tiger woods increased nike revenues over 50 million yearly. fweh i get all excited thinkin that tomorrow is the big day after seeing the share increase, which means IMO the deal could be final now and could be the initial payment going to the celebrity. also look at the numbers in my name... its an actual date! so maybe it was meant to be but hey wishful thinkin is fun! Enjoy
Neil
hop im from southern maryland la plata and waldorf
posted from cell phone
the least i can do, thank you, and u r very welcome.
quite welcome sir